Viatris (VTRS) Revenue (2019 - 2026)
Viatris (VTRS) recorded quarterly Revenue of $3.5 billion in Q1 2026, down 4.71% quarter-over-quarter from $3.7 billion in Q4 2025, and up 8.44% on a YoY basis from $3.2 billion in Q1 2025.
Viatris (VTRS) Revenue (2019 - 2026) Analysis & Trends
Viatris' Revenue history runs 8 years deep, the most recent figure standing at $3.5 billion for Q1 2026.
- In Q1 2026, Revenue rose 8.44% year-over-year to $3.5 billion; the TTM figure through Mar 2026 stood at $14.5 billion (up 1.61% YoY), while the FY2025 annual figure was $14.3 billion, down 3.01% from the prior year.
- Revenue was $3.5 billion for Q1 2026 at Viatris, down from $3.7 billion in the prior quarter.
- In the past five years, Revenue ranged from a high of $4.2 billion in Q1 2022 to a low of -$11.5 billion in Q4 2023.
- Historically, Revenue has averaged $2.9 billion across 5 years, with a median of $3.7 billion in 2025.
- The sharpest annual moves came in 2023 and 2024: Revenue sank 395.21% in 2023, then soared 130.44% in 2024.
- A 5-year view of Revenue shows it stood at $3.9 billion in 2022, then tumbled by 395.21% to -$11.5 billion in 2023, then jumped by 130.44% to $3.5 billion in 2024, then increased by 4.99% to $3.7 billion in 2025, then declined by 4.71% to $3.5 billion in 2026.
- The last three Revenue figures came in at $3.5 billion (Q1 2026), $3.7 billion (Q4 2025), and $3.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.98 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.26 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 781.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 67.54 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 814.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.37 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 39.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 377.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 608.10 Mn |
| 10 | Viatris | - | - | 1.16 Bn | 3.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.52 Bn |
| Dec 31, 2025 | 3.69 Bn |
| Sep 30, 2025 | 3.75 Bn |
| Jun 30, 2025 | 3.58 Bn |
| Mar 31, 2025 | 3.24 Bn |
| Dec 31, 2024 | 3.52 Bn |
| Sep 30, 2024 | 3.75 Bn |
| Jun 30, 2024 | 3.80 Bn |
| Mar 31, 2024 | 3.66 Bn |
| Dec 31, 2023 | -11.55 Bn |
| Sep 30, 2023 | 3.93 Bn |
| Jun 30, 2023 | 3.92 Bn |
| Mar 31, 2023 | 3.73 Bn |
| Dec 31, 2022 | 3.91 Bn |
| Sep 30, 2022 | 4.08 Bn |
| Jun 30, 2022 | 4.11 Bn |
| Mar 31, 2022 | 4.19 Bn |
| Dec 31, 2021 | 4.40 Bn |
| Sep 30, 2021 | 4.54 Bn |
| Jun 30, 2021 | 4.56 Bn |